In the wake of new laws and tighter federal oversight, the FDA has done more than 400 inspections, sent 150 warning letters, and overseen 125 recalls.
A new fluoroquinolone antibiotic, delafloxacin (Baxdela), for acute bacterial skin and skin structure infections (ABSSSI) in adults gained approval yesterday from the US Food and Drug Administration (FDA), according to Melinta Therapeutics, the manufacturer.
In today's Morbidity and Mortality Weekly Report, investigators from the Centers for Disease Control and Prevention (CDC) and several state health departments say a total of 77 clinical cases of the emerging multidrug-resistant fungus Candida auris have now been reported from seven states.
A novel antifungal drug has shown in vitro activity against the emerging fungal pathogen Candida auris, researchers report in Antimicrobial Agents and Chemotherapy.
The Centers for Disease Control and Prevention (CDC) has released a new online tool that will enable users to find out how the agency is financially supporting efforts to combat antibiotic resistance across the country.
The Pew Charitable Trusts has released a set of recommendations for how to ensure more appropriate use of antibiotics in animal agriculture.
The Saudi Arabian Ministry of Health (MOH) reported three new MERS-CoV cases today, and announced the death of a former patient. All three new patients are listed as having primary exposure to the virus, which means it is unlikely they contracted the disease from another person.
The emerging drug-resistant yeast can cause fatal invasive infections.
The US Food and Drug Administration (FDA) has approved a new drug for the treatment of Clostridium difficile infection (CDI), according to a news release its manufacturer, Merck.
An international team of researchers is reporting the first case of the colistin-resistance gene MCR-1 on the Arabian Peninsula.